Quantifying the impact of congenital cardiac co-morbidities on anorectal malformations

Simran Sehdev1, Indre Zaparackaite1, Hannah Bellsham-Revell1

  • 1Evelina London Children's Hospital, London, United Kingdom.

PubMed

Insights

Patients with anorectal malformations (ARM) and congenital heart defects (CHD) experience significant surgical delays for reconstruction. These delays increase the risk of complications, highlighting the need for optimized multidisciplinary care pathways.

Area of Science:

  • Pediatric Surgery
  • Congenital Heart Disease
  • Surgical Outcomes

Background:

  • Anorectal malformations (ARM) are often associated with congenital heart defects (CHD), affecting 10-40% of patients.
  • Surgical management of ARM may be postponed in patients with CHD until their cardiac status is stable, potentially leading to delays in definitive anorectal reconstruction.

Purpose of the Study:

  • To quantify the delays in definitive anorectal reconstruction for ARM patients with CHD.
  • To evaluate the impact of CHD on the incidence of surgical complications in ARM patients.

Main Methods:

  • Retrospective analysis of 62 ARM patients (19 cardiac, 43 non-cardiac) treated at a single center.
  • Patients were categorized based on cardiac functional status and need for cardiac surgery.
  • Statistical analysis included Mann-Whitney-U, Chi-squared, and Poisson regression to compare delays and complication rates.

Main Results:

  • Cardiac ARM patients underwent reconstruction significantly later (396 vs. 175 days, p < 0.001).
  • While the overall complication rate was not significantly different (47% vs. 27%), cardiac status predicted a higher total complication count (IRR = 2.11, p = 0.044).
  • Each day delay from stoma formation to closure increased complication likelihood (OR 1.004, p = 0.029).

Conclusions:

  • Cardiac ARM patients face significant delays in definitive reconstruction and a higher risk of surgical complications.
  • Quantifying these delays and risks is crucial for prognostic counseling and refining multidisciplinary care.
  • Further research is needed to understand the interplay between CHD severity, physiology, and surgical delay on patient outcomes.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
35
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
25
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
40
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.8K
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
23
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
36